中国医院用药评价与分析2024,Vol.24Issue(3) :379-384.DOI:10.14009/j.issn.1672-2124.2024.03.027

子宫内膜癌的内分泌治疗研究进展

Progress of Endocrine Therapy for Endometrial Cancer

黄苏日古嘎 黄笑 曹邦伟
中国医院用药评价与分析2024,Vol.24Issue(3) :379-384.DOI:10.14009/j.issn.1672-2124.2024.03.027

子宫内膜癌的内分泌治疗研究进展

Progress of Endocrine Therapy for Endometrial Cancer

黄苏日古嘎 1黄笑 2曹邦伟2
扫码查看

作者信息

  • 1. 科尔沁右翼前旗人民医院肿瘤科,内蒙古 兴安盟 137713
  • 2. 首都医科大学附属北京友谊医院肿瘤科,北京 100050
  • 折叠

摘要

随着生活质量的提高与生活压力的增加,子宫内膜癌的发病率逐年升高.手术治疗是子宫内膜癌最主要的治疗手段,内分泌治疗作为辅助治疗方法之一也发挥着重要作用,但目前其用药方案与治疗机制仍待进一步探究.因此,本文综合国内外文献,对子宫内膜癌的内分泌治疗药物种类及作用机制、应用范围、疗效检测指标及未来发展方向进行阐述.

Abstract

The incidence of endometrial cancer is increasing year by year as the quality of life improves and the pressure of life increases.Surgical therapy is the most significant treatment of endometrial cancer,endocrine therapy also plays an important role as one of the adjuvant therapy.So far,its medication scheme and treatment mechanism still need to be further explored.Therefore,this review elaborates the variety of endocrine therapy,mechanism,application scope,efficacy detection index and future development direction of endometrial cancer based on domestic and foreign literature.

关键词

子宫内膜癌/内分泌治疗/研究进展

Key words

Endometrial cancer/Endocrine therapy/Research progress

引用本文复制引用

出版年

2024
中国医院用药评价与分析
中国医药生物技术协会,中国药房杂志社

中国医院用药评价与分析

CSTPCD
影响因子:1.142
ISSN:1672-2124
参考文献量41
段落导航相关论文